Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE: Ensitrelvir in Hospitalized COVID-19 Patients
NCT05605093Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- Dec 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of ensitrelvir in coronavirus disease 2019 (COVID-19), sponsored by University of Minnesota. Started Dec 2022; status: terminated.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05605093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05605093.